VANCOUVER, British Columbia and BOSTON, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering ...
Inhaling xenon gas reduced neuroinflammation and brain atrophy while increasing protective neuronal states in mouse models of Alzheimer's disease, found a new study. The findings were published in ...
The international team describes their results and the underlying molecular mechanism in Cell Metabolism. Ergothioneine is a natural compound found in certain fungi such as oyster or shiitake ...
Share on Pinterest Scientists are investigating xenon gas as a potential treatment for Alzheimer’s. Westend61/Getty Images Researchers continue to search for effective treatments for Alzheimer ...
The study found that Xenon gas inhalation suppressed neuroinflammation, reduced brain atrophy, and increased protective neuronal states in mouse models of Alzheimer's disease. Results are ...
Xenon gas emerges as a promising treatment for Alzheimer’s, showing benefits in preclinical tests such as reducing brain atrophy and enhancing neuron protection, with human trials starting soon. A ...
Xenon gas inhalation shows potential in treating Alzheimer's disease by reducing neuroinflammation, brain atrophy, and enhancing protective neuronal states in mouse models.
The gas xenon, like the other noble, or inert, gases, is known for doing very little. The class of elements, because of its molecular structure, don’t typically interact with many chemicals.
The study found that Xenon gas inhalation suppressed neuroinflammation, reduced brain atrophy, and increased protective neuronal states in mouse models of Alzheimer's disease. A phase 1 clinical ...
Study finding Xenon gas could protect against Alzheimer’s disease leads to start of clinical trial
New research from Mass General Brigham and Washington University School of Medicine in St. Louis found Xenon gas inhalation reduced neurodegeneration and boosted protection in preclinical models o ...
Rafael Rodríguez believes that "this molecule could become a drug to treat the symptoms of dementia, at least during the initial stages of the disease, because we have already seen that the body ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results